Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Livagen

Lys-Glu-Asp-Ala, Tetrapeptide KEDA

A bioregulatory tetrapeptide that decondenses chromatin, modulates gene expression, and supports liver regeneration and immune function.

Molecular Profile
Formula C18H31N5O9
Mol. Weight 461.5 g/mol
Sequence Gly-Glu-Pro-Pro...
Route
Subcutaneous (SC)
100-300 mcg/day
SUB
Oral
0.1-1 mg/kg (animal studies)
ORA

How It Works

How It Works: Livagen acts as a bioregulator by interacting with DNA to decondense chromatin and influence gene expression, promoting cellular rejuvenation and organ function.

  • Chromatin Decondensation: Reduces heterochromatin, activating silenced genes particularly in aging cells.
  • Gene Expression Modulation: Increases expression of ribosomal genes and restores protein synthesis rhythms in liver cells.
  • Enzyme Inhibition: Inhibits enkephalin-degrading enzymes, enhancing opioid system activity.
  • Immunomodulation: Enhances lymphocyte function and overall immune response.

Latest Clinical Trials

Completed NA NCT04243395

Protein Source on Plasma Amino Acid Concentrations In Older Adults

Purdue University
INTERVENTIONAL
Updated Dec 15, 2025
Completed NA NCT04072770

Bioavailability of Protein and Amino Acids of Pea Protein Isolate in Healthy Volunteers

Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
INTERVENTIONAL
Updated Dec 15, 2025
View All Clinical Trials

Latest Studies

Utility 2
pubmed Apr 1, 2007

Activation of pericentromeric and telomeric heterochromatin in cultured lymphocytes from old individuals.

Lezhava. Teimuraz T; Jokhadze. Tina T

The study shows that in cells taken from very old people, the DNA becomes more tightly packed (heterochromatin) with age, which can silence genes. Adding the peptide Livagen in the lab helped loosen this packing and reduced DNA damage caused by cobalt ions. However, the work was done only in cultured lymphocytes, not in living humans.

Utility 2
pubmed 2002

Effects of Livagen peptide on chromatin activation in lymphocytes from old people.

Khavinson. V Kh VKh; Lezhava. T A TA; Monaselidze. J G JG; Dzhokhadze. T A TA; D...

The study found that the synthetic peptide Livagen can change the way DNA is packaged in white blood cells from older people, making certain genes more active. It seems to loosen tightly packed DNA regions and turn on genes that usually get turned off with age, which could be linked to healthier cells.

Utility 1
pubmed 2007

[Variability of radiation-induced adaptive response in old age individuals and their correction by Peptide bioregulator -Livagen].

Dzhokhadze. T A TA; Buadze. T Zh TZh; Dvalishvili. N A NA; Lezhava. T A TA

A lab study found that blood cells from older people still react to low‑dose radiation, and a peptide called Livagen seemed to help fix stress responses in those cells, but the work was done in test tubes and didn’t give any real‑world dosing or usage advice.

Browse All Studies